Cargando…
Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study
Chronic thromboembolic pulmonary hypertension (CTEPH) is believed to involve both vascular obstruction and vasoconstriction; hence, pulmonary vasodilators such as riociguat may be beneficial. Acute vasoreactivity testing (AVT) is seldom performed routinely in CTEPH patients, so there is limited unde...
Autores principales: | Frantz, Robert P., Leopold, Jane A., Hassoun, Paul M., Hemnes, Anna R., Horn, Evelyn M., Mathai, Stephen C., Rischard, Franz P., Larive, A. Brett, Tang, W.h. Wilson, Park, Margaret M., Hill, Nicholas S., Rosenzweig, Erika B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817070/ https://www.ncbi.nlm.nih.gov/pubmed/36618713 http://dx.doi.org/10.1002/pul2.12181 |
Ejemplares similares
-
Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study
por: Naranjo, Mario, et al.
Publicado: (2023) -
Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope
por: Linder, Alexandra N., et al.
Publicado: (2022) -
Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Xu, Qi-Xia, et al.
Publicado: (2017) -
Cholesterol: A Novel Regulator of Vasoreactivity in Pulmonary
Arteries
por: Grimmer, Benjamin, et al.
Publicado: (2020) -
Prognostic value of longitudinal vasoreactivity in pediatric pulmonary hypertension
por: Evers, Patrick D., et al.
Publicado: (2022)